Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) (e.g., Semaglutide (Ozempic) and Tirzepatide (Mounjaro)) have historically been prescribed to treat Type-2 Diabetes Mellitus (T2DM), but their efficacy in managing weight loss has increased their role in weight management treatments (1, 2)
$200.00 Free Shipping on All Orders $300+ Product Usage: For Research Use Only Not for Human or Veterinary Use This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the FDA
Medication works best with nutrition, movement, and follow-up care
While other GLP-1R agonists have shown promising outcomes in mitigating cancer progression, the association between some GLP-1R agonists and an increased risk of cancer remains a topic requiring more profound investigation
Finally, we only used immunohistochemical staining to demonstrate the expression of GLP-1R in thyroid tissue
The vasoprotective effects align neatly with the mechanistic picture: a compound that promotes angiogenesis and modulates nitric oxide would predictably stabilize vascular function across a range of stressors